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Abstract
A novel parvovirus, provisionally named Gorilla Bocavirus species 1 (GBoV1), was identified in four stool samples from
Western gorillas (Gorilla gorilla) with acute enteritis. The complete genomic sequence of the new parvovirus revealed three
open reading frames (ORFs) with an organization similar to that of known bocaviruses. Phylogenetic analysis using
complete capsid and non structural (NS) gene sequence suggested that the new parvovirus is most closely related to
human bocaviruses (HBoV). However, the NS ORF is more similar in length to the NS ORF found in canine minute virus and
bovine parvovirus than in HBoV. Comparative genetic analysis using GBoV and HBoV genomes enabled characterization of
unique splice donor and acceptor sites that appear to be highly conserved among all four HBoV species, and provided
evidence for expression of two different NS proteins in all primate bocaviruses. GBoV is the first non-human primate
bocavirus identified and provides new insights into the genetic diversity and evolution of this highly prevalent and recently
discovered group of parvoviruses.
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Introduction
Parvoviruses, members of family Parvoviridae, are small, non-
enveloped icosahedral viruses with single-stranded linear DNA
genomes that frequently infect animals through the fecal-oral
route[1]. Parvoviruses are ubiquitous and can cause a broad
spectrum of diseases in animals, including enteritis, panleukopenia,
hepatitis, erythrocyte aplasia, immune complex–mediated vascu-
litis, and cerebellar ataxia [1]. Efficacious vaccines against animal
parvovirus infections are widely employed [2,3,4,5,6].
The family Parvoviridae as currently defined, comprises two sub-
families, Densovirinae and Parvovirinae, that infect non-vertebrate and
vertebrate hosts, respectively[1]. The International Committee on
Taxonomy of Viruses (ICTV) has further classified the sub-family
Parvovirinae into five genera: Dependovirus, Bocavirus, Erythro-
virus, Parvovirus and Amdovirus. Bocaviruses are unique among
parvoviruses, as they contain a third ORF between non-structural
and structural coding regions [7]. The genus Bocavirus includes
the bovine parvoviruses, canine minute viruses and four species of
human bocaviruses (HBoV1 -4)[1,8,9,10,11,12].
HBoV1 infection has been linked with mild to severe lower
respiratory tract infections in children, frequently in association
with other viral infections [8,13,14,15,16,17,18,19,20]. HBoV1
has also been detected at low frequency in stool samples although
association with diarrhea appears weaker than with respiratory
symptoms [9,10,21,22,23,24]. HBoV1 strains show a low degree
of genetic variability world-wide (35,36). HBoV2 was recently
identified in stool samples of Pakistani children [12]. Lower
frequencies of HBoV2 were detected in the stool of Scottish adults
and children [12]. A third bocavirus species, HBoV3, as well as
HBoV2, were recently found in stool samples from Australian
children with diarrhea [10]. HBoV4 was first identified in stool
samples of children from Nigeria and Tunisia[11].
Group-reactive or pan-PCR approaches have been used to
identify new viruses in human, animal and environmental samples
[25,26,27,28,29]. We recently discovered two novel HBoV species
using this approach [11]. In a survey for divergent bocaviruses in
other non-human primates, we studied stool samples from three
groups of western gorillas (Gorilla gorilla) with enteritis using pan-
bocavirus PCR assay. This work describes the nearly complete
genome of the first non-human primate bocavirus species
identified in four stool samples of gorillas, tentatively named
Gorilla Bocavirus species 1 (GBoV1).
Materials and Methods
Samples and source
All stool samples studied were from western gorillas (Gorilla
gorilla) in a captive colony in North America. Samples were
collected during April 2009, during an outbreak of enteritis
resulting in diarrhea among three different groups of Gorillas.
Group A=12 animals, group B=7 animals and group C=4
animals. All fecal material was recovered from the floor of zoo
enclosures. Samples were identified by group of origin, but the
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not always known.
Sample processing and pan-bocavirus PCR assay
Stool samples were diluted 1:9 with Hank’s Buffered Saline
Solution (Gibco-BRL), mixed with glass beads, vigorously vortexed
and centrifuged twice at 2700 g for 10 min. Clarified supernatants
(250 ml) were used for total nucleic acid extraction using the
NucliSENS easyMAG system (Biomerieux). Total nucleic acids
were eluted in 50 ml DEPC-treated water. PCR primers panBOV-
F1 (59-TAATGCAYCARGAYTGGGTIGANCC -39) and pan-
BOV-R1 (59- GTACAGTCRTAYTCRTTRAARCACCA-39)
were used for the first round of hemi-nested PCR; while primers
panBOV-F2 (59- GCAYCARGAYTGGGTIGANCCWGC – 39)
and panBOV-R1 (same as first round) were used for the second
round of hemi-nested PCR. For the first round of nested PCR,
5 ml of each specimen DNA was mixed with 5.2 ml1 0 6
polymerase reaction buffer (Qiagen), 1.2 ml each dNTP
(10 mM), 50 pmol forward (both panBOV-F1) and reverse primer
(panBOV-R1), 1 ml HotStart Taq DNA polymerase (Qiagen) and
31 ml DEPC-treated water, in a total reaction volume of 50 ml.
The reaction was performed using initial denaturation at 95 C
for 7 min, followed by six cycles of 95uC for 40 sec, 60uC for
45 sec and 68uC for 30 sec, then 35 cycles of 95uC for 30 sec,
57uC for 30 sec and 68uC for 30 sec, and final extension at 72uC
for 10 min. During the first round of PCR, the first six cycles were
done at a high annealing temperature to increase stringency and
then remaining cycle at lower temperature to facilitate primer
hybridization by tolerating some nucleotide mismatches. For the
second round of hemi-nested PCR, identical cycling conditions
were used, with an annealing temperature of 64uC for the first six
cycles and annealing temperature of 58uC for the remaining 35
cycles. The reaction mixture for the second round was added with
0.5 ml PCR product from the first round. Products were visualized
following electrophoresis on 2% agarose gel. PCR products
showing positive bands of approximately 290 bp, corresponding
to the highly conserved amplified NS gene fragment, were purified
using a PCR purification kit (Qiagen) and directly sequenced from
both directions.
To increase the sensitivity of the PCR specific primers
targeting the same conserved gene region were used to screen all
23 samples. PCR primers GBoV-F1 (59- GCACCAAGACTG-
GGTGGAACC – 39)a n dG B o V - R 1 ( 5 9- GCACCAGTGTAG-
TAGAGCTGC- 39) were used for the first round of nested
PCR. Primers GBoV-F2 (59- CAAGACTGGGTGGAAC-
CAGC-39) and GBoV-R2(59- GCACCAGTGTAGTAGAGC-
TGCAAT- 39) were used for the second round. For the first
round of nested PCR, 5 ml of each specimen DNA was mixed
with 5.2 ml1 0 6polymerase reaction buffer (Qiagen), 1.2 mle a c h
dNTP (10 mM), 20 pmol forward (GBoV-F1) and reverse
primer (GBoV-R1), 1 ml HotStart Taq DNA polymerase
(Qiagen) and 31 ml DEPC-treated water, in a total reaction
volume of 50 ml. The reaction was performed using initial
denaturation at 95 C for 7 min, followed by six cycles of 95uC
for 40 sec, 61uC for 45 sec and 72uC for 30 sec, then 35 cycles
of 95uC for 30 sec, 59uC for 30 sec and 72uC for 30 sec, and
final extension at 72uC for 10 min. For the second round of
nested PCR, identical cycling conditions were used, with an
annealing temperature of 60uC for the first six cycles and
annealing temperature of 58uC for the remaining 35 cycles. The
reaction mixture for the second round was added with 0.5 ml
PCR product from the first round. Products were visualized
following electrophoresis on 2% agarose gel. PCR products
showing positive bands of approximately 290 bp, corresponding
to the highly conserved amplified NS gene fragment, were
purified using a PCR purification kit (Qiagen) and directly
sequenced from both directions.
Complete genome sequencing and phylogenetic analysis
Complete genome of the GBoV1 was acquired using primer
walking approach as previously described [11]. In brief, each
extension step of PCR used one primer specific for the novel virus
sequence and other degenerated to hybridize all known bocavirus
sequences. After the complete genome was assembled, each base is
sequenced in triplicate to confirm the sequence. The near
complete genome of GBoV1 is submitted to Genbank under
accession number HM145750.
To determine the sequence relationship between GBoV1 and
other known bocavirus species, at least one representative virus
member, including the reference genome from each species and
their translated protein sequences, were used for generating
sequence alignments. Sequences used for the comparison
comprised the following: HBoV1 (GenBank accession no. 19616-
8955, 161137732, 149389636, 125616893, 161137737, 149389-
621, 149389676, 223670836, 196168950, 149389626, 284799140,
256692975, 149389721, 149389656, 241995009, 223951374,
196169010, 149389641, 92087153, 226434473, 223670876,
223670861, 196169000, 196168975, 196168960, 149389651,
149389611, 66356133, 66356128, 219879196, 196168985,
196168970, 196168945, 149389711, 149389706, 149389696,
149389661, 149389646, 149389606, 125616883, 196168995,
149389701, 149389691, 149389681, 149389671, 149389666,
149389631, 130918044, 84873482, 260779772, 256692980,
226434468, 223670851, 223670846, 223670841, 223670831,
125719360, 226434443), HBoV2 (GenBank accession no. 24199-
4927, 213012741, 237690160, 237690166, 158714105, 238476-
986, 158713998, 290565732, 213012746, 290565722, 213012751,
284080644, 237690154, 284080639, 290565727), HBoV3 (Gen-
Bank accession no. 238476991,206572554,290565737,237690178,
237690184), HBoV4 (GenBank accession no. 289163341), canine
minute virus (GenBank accession no. NC_004442) and bovine
parvovirus-1 (GenBank accession no. 9627190). Phylogenetic anal-
yses of CLUSTAL W aligned regions were carried out by neighbour
joining of nucleotide or amino acid p-distances, implemented in the
program MEGA4[30]. Bootstrap resampling was carried out to
demonstrate robustness of groupings. Recombination analysis was
performed by Symplot[31], using reference genomes of all four
HBoV species and GBoV1. To assess similarity across the genomes,
sequence scans were performed using a fragment length of 300 bases
and an increment of bases between fragments.
Results
Identification and near complete genome of GBoV1
Twenty-three stool samples collected during an outbreak of
enteritis with diarrhea in captive gorillas were studied for presence
of divergent bocaviruses related to known HBoV. Four samples
(two each from group B and C) yielded amplification products
using a pan-bocavirus PCR. To increase the sensitivity of the PCR
specific primers targeting GBoV1 sequence were used to screen all
samples, but no additional samples were found positive. Prelim-
inary sequence analysis confirmed presence of a divergent
bocavirus with 89% nucleotide and 92% amino acid identity to
HBoV1. The causal relationship between the virus and disease was
not determined.
Similar to other known bocaviruses, the GBoV1 genome is
predicted to contain three large ORFs. ORF1 encodes
nonstructural (NS) protein; ORF2 codes for overlapping VP1/
Non-Human Primate Bocavirus
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protein gene comprises 2412 nt and is predicted to code for 804
amino acids (aa) with a mass of approximately 91 kDa, making
it the second longest NS protein encoded by a bocavirus
(HBoV1 – 781 aa, HBoV2 -777 aa, HBoV3 – 780 aa and
HBoV4 – 776 aa, canine minute virus - 774 aa and bovine
parvovirus - 860 aa). Conserved motifs associated with rolling
circle replication, helicase and ATPase are present within
ORF1. The GBoV1 virion protein gene comprises 2013 nt
and is predicted to code for two structural proteins VP1 and
VP2 of 671 aa and 542aa length, respectively. Within ORF2,
the phospholipase A2 motifs required for parvovirus infectivity
situated within the VP1-unique (VP1u) region were also found
in association with calcium-binding loop and catalytic residues.
The occurrence of the non-structural protein NP1 encoded by
an ORF in the middle of the genome is a unique feature of
bocaviruses. The GBoV NP1 gene comprises 657 nt and is
predicted to code for a highly basic and stable 219 aa protein
with a mass of approximately 26 kDa. NP1 is a highly
phosphorylated protein of currently undetermined function
[32]; NP1 differs in length between different HBoV species,
ranging from 219 aa (HBoV1), 214 aa (HBoV2A1, HBoV3), 215
aa (HBoV1A2, HBoVA3, HBoVB) and 218 aa (HBoV4).
Phylogenetic relationship of GBoV1 with other
bocaviruses
To determine the relationship between GBoV1 and other
members of the Bocavirus genus, phylogenetic analyses of the 3
large ORFs - NS1, NP1 and VP1/VP2 - were performed, by use of
both nt and deduced aa sequences. In all 3 genomic regions, the
GBoV1 was more similar to HBoV1 or HBoV3 than to the other
human or animal bocavirus species (CnMV and BPV1), the latter of
which consistently occupied an outlier position with regard to the
clade containing all primate bocavirus sequence (Fig.1 A and B).
Most HBoV species include several genotypes. Thus, to
ensure accurate classification of GBoV1 we examined complete
capsid sequences of all the HBoV variants in the GenBank.
Phylogenetic analyses suggested that although GBoV1 is
genetically closest to HBoV1, the distance between the two
viruses is more than that observed within (intra-species distance)
any of the four reported HBoV species (Fig.1 A)[11]. Moreover,
as HBoV1 was the most genetically homogenous bocavirus
species, GBoV1 is more likely to represent a separate genetic
clade. Phylogenetic clustering of primate bocaviruses using the
different genes was found to be consistent except for HBoV3,
which being a recombinant virus[11], clustered in NS gene with
HBoV1 clade and in other genes with HBoV2 clade (Fig.1-B).
Figure 1. Phylogenetic analysis of GBoV1. (A) Full length structural protein (VP1/2) sequences of all HBoV and animal bocavirus strains available
in GenBank were used to determine phylogeny of GBoV1 by neighbor-joining analysis of pairwise distances between translated amino acid
sequences. Bootstrap re-sampling was used to determine robustness of individual clades (values above 70% shown above the branches). (B) The 4
major open reading frames of GBoV1 were analyzed using maximum likelihood composition analysis method (MEGA4.1) comparing pairwise
distances of translated sequences of representative variants (reference sequence) of all four HBoV species. Accession numbers of sequences used
precedes the name of corresponding bocavirus species.
doi:10.1371/journal.pone.0011948.g001
Non-Human Primate Bocavirus
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suggesting it is not an inter-species recombinant virus (Fig.1-B).
Phylogenetic trees using different genes also showed that the
genetic distance of GBoV1 and its closest related virus (HBoV1)
was more than that between- HBoV2 and 4 (in all genes), as
well between HBoV2, 3 and 4 (in VP1 and VP2 genes) (Fig.1-B).
These relationships are described in Table 1 in terms of pairwise
nt and aa distances. Differences between GBoV1 and HBoV1
and HBoV2 in VP1/2 genes were substantially greater (12.1–
12.8 and 13.1–14%, respectively) than those between either
HBoV2 and HBoV3 (9.2–10.5 and 9.4–10.8%) or HBo2 and
HBoV4 (9.6–11.4 and 9.6–11.3%) or HBoV3 and HBoV4 (7.8–
8.8 and 7.9–8.9%). However the genetic distance between the
VP1/2 gene of HBoV1 and HBoV2 (19.6–21.8 and 20.3–20.5)
was the largest observed between primate bocavirus species
(Table 1, shaded numbers).
The International Committee on Taxonomy of Viruses (ICTV)
criteria for classification of Bocaviruses establishes that members
of each species are probably antigenically distinct and that
natural infection is confined to a single host species. Species are
defined as ,95% homologous NS gene DNA sequence (http://
www.ncbi.nlm.nih.gov/ICTVdb/ICTVdB/or http://phene.cpmc.
columbia.edu/Ictv/fs_parvo.htm). While the antigenic properties of
GBoV1 were not studied here, its isolation from a different natural
host (gorilla) and .5% genetic distance in NS gene compared to
other known bocavirus species, suggest that GBoV1 should be
classified as prototype virus of a new bocavirus species.
Unique genomic features of GBoV1 and recombination
analysis
The genomic organization of all four HBoV species is
remarkably similar to that of animal bocaviruses, except that
their ORF1 encodes a shorter NS protein (639–650 aa),
compared to the longer NS protein of animal bocaviruses (770–
860 aa) (Fig.2A). We recently showed the presence of highly
conserved potential RNA splicing signals in all HBoV species
near the end of the smaller NS2 ORF and the putative second
exon encoding the C-terminal region of NS1 (Fig. 2B)[11]. We
reported that the putative elongated NS1 resulting from such a
spliced transcript in HBoV encodes a 775–781 aa protein with a
carboxy terminus that has weak similarity (25–34% aa identity) to
that of other, non-human bocaviruses. Interestingly, the putative
NS protein of GBoV1, which is predicted to arise from an intact
(non-spliced) transcript, has higher protein similarity (58–74% aa
identity) to the extended NS protein (post splicing transcript) of all
HBoVs (Fig.2C). Moreover, although no stop codon was found in
NS gene of GBoV1, the elements required for RNA splicing were
present GBoV1 as in all HBoV species (Fig. 2C, splice donor,
branch and acceptor site). Analysis of recently reported novel
HBoV species (HBoV3) showed it as a recombinant virus of
HBoV1 and HBoV2, suggesting interspecies recombination
among bocaviruses. We compared genome wide distances among
HBoV1, HBoV2 and GBoV1 genomes using Symplot analysis
[31] but found no evidence of interspecies recombination.
However, comparison including HBoV3 and HBoV4 genomes
indicates frequent recombination between all primate species
(data not shown).
Discussion
We report the identification and near complete genomic
sequencing of the first non-human primate bocavirus. As it was
found in stool samples of gorillas, we have provisionally named this
virus GBoV1. Following ICTV guidelines we propose classifica-
tion of this novel virus as the prototype member of a new species in
the genus Bocavirus [1]. The pan-PCR approach used to discover
GBoV1 was similar to that recently used to identify HBoV3 and
HBoV4 [11].
Several studies report higher prevalence of HBoV1 in respiratory
sample and of HBoV2, 3 and 4 in gastrointestinal samples,
suggesting that different species may vary in tissue tropism
[7,9,10,11,12,13,14,16,19,21,22,33,34,35,36,37,38,39,40,41]. We
do not know whether GBoV1 shares this propensity to tissue
tropism. Comparative genetic analysis of different HBoV strains
circulating worldwide indicate that whereas HBoV1 is homogenous
with low mean genetic diversity (,1% nt or ,0.5% aa), HBoV2 is
heterogeneous with higher mean genetic diversity (,4.6% nt or
,6.1% aa)[11]. Current data do not allow us to determine the
genetic diversity of GBoV1. However, the discovery of GBoV1
indicates that this recently discovered group of viruses are more
widely dispersed than previously reported and raises the possibility
that more novel viral species may be found in other animal species.
A unique feature of the GBoV1 genome was the presence of a
longer NS protein ORF compared to that encoded by most closely
related HBoV. Significant and high similarity (58 to 74% aa
identity) of the extended NS protein of all HBoV species with
GBoV1 NS protein supports expression of two NS proteins of
variable length in HBoVs [11]. The proposed NS1 RNA splicing
and NS1 protein expression itself were detected using Northern
blots and NS1 C-termini specific sera, respectively, in 293 and
human epithelial cells transfected with plasmids expressing
HBoV1 transcripts [42]. Despite their high genetic diversity,
Table 1. Comparison of pairwise nucleotide and amino acid
(bold typeface) distances (p-distance) of all four genes
between GBoV1 and HBoV species confirms GBoV1 as
prototype of a new bocavirus species.
GBoV1 HBoV1 HBoV2 HBoV3 HBoV4
GBoV1
NS
NP
VP1
VP2
-
-
-
-
7.8
12.8
12.1
12.8
24.2
30.7
17.2
18.9
8.9
16.1
16.9
18.9
25.0
28.3
16.7
18.7
HBoV1
NS
NP
VP1
VP2
8.0
12.8
13.1
14.0
-
-
-
-
21.5
31.6
19.6
21.8
8.5
16.6
19.4
21.7
22.3
30.2
19.1
21.7
HBoV2
NS
NP
VP1
VP2
24.3
31.3
18.0
19.6
21.8
31.8
20.3
22.5
-
-
-
-
23.5
29.9
9.2
10.5
5.7
11.3
9.6
11.4
HBoV3
NS
NP
VP1
VP2
8.9
16.1
17.4
19.1
8.6
16.5
19.8
21.9
23.6
30.8
9.4
10.8
-
-
-
-
24.5
30.8
7.8
8.8
HBoV4
NS
NP
VP1
VP2
25
29.0
17.2
19.0
22.5
30.8
19.5
21.9
5.6
12.1
9.6
11.3
24.6
31.8
7.9
8.9
-
-
-
-
doi:10.1371/journal.pone.0011948.t001
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conserved NS gene RNA splicing sites, suggestive of expression of
two different NS proteins in GBoV. However it is unclear whether
only HBoV requires expression of a truncated NS protein and
whether the presence of a truncated NS protein is advantageous
for HBoV replication in humans.
Parvoviruses have the capacity to change host species [2,43].
The observation that GBoV1 is more closely related to HBoV1
than any other two HBoV species are to one another, suggests the
possibility of cross-species transmission. Single-stranded DNA
parvoviruses have been shown to have a mutation rate
approaching that of RNA viruses [44,45]. Moreover, both the
expression of a truncated NS protein (presence of stop cordon in
all HBoV species) and the presence of splicing mechanism that
generates a longer NS protein is unique to all HBoV species, and
suggests the derivation of all HBoV species from a common
ancestor. We conclude that although interspecies transmission of
bocaviruses may have occurred in ancient times, the genomic
organization of GBoV1 indicates that there has been species
specificity of bocaviruses in primates for a long time. In absence of
any known animal model for HBoV, identification of GBoV1 and
other non-human primate bocaviruses will offer opportunity to
study the HBoV pathogenesis and disease.
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